EORTC/EMA workshop proposes international path for treatment optimisation studies
EORTC/EMA WORKSHOP PROPOSES INTERNATIONAL PATH FOR TREATMENT OPTMISATION STUDIES [...]
EORTC CEO, appointed co-chair of ACT EU Advisory Group
EORTC CEO, APPOINTED CO-CHAIR OF ACT EU ADVISORY GROUP [...]
Meet Volha: Medical Physicist Fellow at EORTC
MEET VOLHA: MEDICAL PHYSICIST FELLOW AT EORTC [...]
Breaking New Ground in Glioblastoma Treatment: The LEGATO Study
Breaking New Ground in Glioblastoma Treatment: The LEGATO Study [...]
Navigating Breast Cancer Research Funding Challenges: EORTC BCG and BIG Insights
Navigating Breast Cancer Research Funding Challenges: EORTC BCG and BIG [...]
EORTC CEO Joins Economist Impact World Cancer Series to Advocate for Improved Clinical Trial Access
EORTC CEO Joins Economist Impact World Cancer Series to [...]
Celebrating EORTC’s 60th Anniversary: One Year On
Celebrating EORTC's 60th Anniversary: One Year On [...]
EORTC strategic meeting with Middle Eastern Ambassadors
EORTC strategic meeting with Middle Eastern Ambassadors [...]
Publication of 2022 EORTC Annual Report
Publication of 2022 EORTC Annual Report This [...]
EORTC QUALITY OF LIFE (QOL) GROUP: 40 YEARS OF IMPROVING THE QUALITY OF LIFE FOR CANCER PATIENTS
EORTC QUALITY OF LIFE (QOL) GROUP: 40 YEARS OF [...]
